Literature DB >> 16309676

Morris water maze search strategy analysis in PDAPP mice before and after experimental traumatic brain injury.

David L Brody1, David M Holtzman.   

Abstract

Traumatic brain injury (TBI) is a common cause of cognitive dysfunction and a major risk factor for Alzheimer's disease (AD). PDAPP mice, a transgenic line overexpressing a mutant human amyloid precursor protein (APP) implicated in familial AD, have markedly impaired behavioral performance in the Morris water maze relative to wild-type (WT) littermates. Performance further deteriorates following experimental TBI in both PDAPP and WT mice. However, the aspects of cognitive function involved are not well understood. Here, we have analyzed search strategies used in the water maze by 3-4 month old PDAPP and WT C57Bl6 littermates both before and after moderate controlled cortical impact TBI. Prior to TBI, PDAPP mice used less spatial strategies and more nonspatial systematic strategies and strategies involving repetitive looping than WT mice. With training, PDAPP mice used more spatial strategies and less repetitive looping. After TBI, PDAPP mice lost use of spatial strategies and relied more on repetitive looping. TBI in WT mice also reduced their use of spatial strategies but instead caused a switch to nonspatial systematic strategies. We also analyzed changes in the efficiency with which mice used each individual strategy, but found that differences in which strategies were used quantitatively accounted for most of the differences in performance between groups. These results demonstrate that suboptimal search strategy use in addition to effects on spatial learning and memory underlies the impaired performance of PDAPP mice and further deterioration following TBI. Human TBI patients may have analogous poor use of problem solving strategies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16309676      PMCID: PMC1913184          DOI: 10.1016/j.expneurol.2005.10.020

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  39 in total

1.  Behavioral assessment of Alzheimer's transgenic mice following long-term Abeta vaccination: task specificity and correlations between Abeta deposition and spatial memory.

Authors:  G W Arendash; M N Gordon; D M Diamond; L A Austin; J M Hatcher; P Jantzen; G DiCarlo; D Wilcock; D Morgan
Journal:  DNA Cell Biol       Date:  2001-11       Impact factor: 3.311

2.  Age-independent and age-related deficits in visuospatial learning, sleep-wake states, thermoregulation and motor activity in PDAPP mice.

Authors:  Salvador Huitrón-Reséndiz; Manuel Sánchez-Alavez; Roger Gallegos; Greta Berg; Elena Crawford; Jeannie L Giacchino; Dora Games; Steven J Henriksen; José R Criado
Journal:  Brain Res       Date:  2002-02-22       Impact factor: 3.252

3.  Reversal of cognitive deficit of apolipoprotein E knockout mice after repeated exposure to a common environmental experience.

Authors:  J Grootendorst; E R de Kloet; S Dalm; M S Oitzl
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

4.  Behavioral deficits in APP(V717F) transgenic mice deficient for the apolipoprotein E gene.

Authors:  J C Dodart; C Mathis; K R Bales; S M Paul; A Ungerer
Journal:  Neuroreport       Date:  2000-02-28       Impact factor: 1.837

5.  Traumatic brain injury in the United States: A public health perspective.

Authors:  D J Thurman; C Alverson; K A Dunn; J Guerrero; J E Sniezek
Journal:  J Head Trauma Rehabil       Date:  1999-12       Impact factor: 2.710

6.  A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease.

Authors:  G Chen; K S Chen; J Knox; J Inglis; A Bernard; S J Martin; A Justice; L McConlogue; D Games; S B Freedman; R G Morris
Journal:  Nature       Date:  2000 Dec 21-28       Impact factor: 49.962

Review 7.  Dissecting the behaviour of transgenic mice: is it the mutation, the genetic background, or the environment?

Authors:  D P Wolfer; H P Lipp
Journal:  Exp Physiol       Date:  2000-11       Impact factor: 2.969

8.  Apolipoprotein E4 influences amyloid deposition but not cell loss after traumatic brain injury in a mouse model of Alzheimer's disease.

Authors:  Richard E Hartman; Helmut Laurer; Luca Longhi; Kelly R Bales; Steven M Paul; Tracy K McIntosh; David M Holtzman
Journal:  J Neurosci       Date:  2002-12-01       Impact factor: 6.167

9.  Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model.

Authors:  Jean-Cosme Dodart; Kelly R Bales; Kimberley S Gannon; Stephen J Greene; Ronald B DeMattos; Chantal Mathis; Cynthia A DeLong; Su Wu; Xin Wu; David M Holtzman; Steven M Paul
Journal:  Nat Neurosci       Date:  2002-05       Impact factor: 24.884

10.  Reversible memory loss in a mouse transgenic model of Alzheimer's disease.

Authors:  Linda A Kotilinek; Brian Bacskai; Marcus Westerman; Takeshi Kawarabayashi; Linda Younkin; Bradley T Hyman; Steven Younkin; Karen H Ashe
Journal:  J Neurosci       Date:  2002-08-01       Impact factor: 6.167

View more
  73 in total

1.  CR8, a selective and potent CDK inhibitor, provides neuroprotection in experimental traumatic brain injury.

Authors:  Shruti V Kabadi; Bogdan A Stoica; Marie Hanscom; David J Loane; Giorgi Kharebava; Michael G Murray Ii; Rainier M Cabatbat; Alan I Faden
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

2.  Deferoxamine attenuates iron-induced long-term neurotoxicity in rats with traumatic brain injury.

Authors:  Lijun Zhang; Rong Hu; Mei Li; Fei Li; Hui Meng; Gang Zhu; Jiangkai Lin; Hua Feng
Journal:  Neurol Sci       Date:  2012-04-27       Impact factor: 3.307

3.  Cognitive evaluation of traumatically brain-injured rats using serial testing in the Morris water maze.

Authors:  Hilaire J Thompson; David G LeBold; Niklas Marklund; Diego M Morales; Andrew P Hagner; Tracy K McIntosh
Journal:  Restor Neurol Neurosci       Date:  2006       Impact factor: 2.406

4.  Zinc and copper modulate Alzheimer Abeta levels in human cerebrospinal fluid.

Authors:  Dorothea Strozyk; Lenore J Launer; Paul A Adlard; Robert A Cherny; Andrew Tsatsanis; Irene Volitakis; Kaj Blennow; Helen Petrovitch; Lon R White; Ashley I Bush
Journal:  Neurobiol Aging       Date:  2007-12-18       Impact factor: 4.673

5.  Closed head injury in an age-related Alzheimer mouse model leads to an altered neuroinflammatory response and persistent cognitive impairment.

Authors:  Scott J Webster; Linda J Van Eldik; D Martin Watterson; Adam D Bachstetter
Journal:  J Neurosci       Date:  2015-04-22       Impact factor: 6.167

6.  Repeated mild traumatic brain injury causes chronic neuroinflammation, changes in hippocampal synaptic plasticity, and associated cognitive deficits.

Authors:  Stephanie L Aungst; Shruti V Kabadi; Scott M Thompson; Bogdan A Stoica; Alan I Faden
Journal:  J Cereb Blood Flow Metab       Date:  2014-04-23       Impact factor: 6.200

Review 7.  Liver macrophages in healthy and diseased liver.

Authors:  Zeinab Abdullah; Percy A Knolle
Journal:  Pflugers Arch       Date:  2017-03-14       Impact factor: 3.657

8.  Novel application of a Radial Water Tread maze can distinguish cognitive deficits in mice with traumatic brain injury.

Authors:  Marcella M Cline; Josh C Yumul; Lisa Hysa; Dalia Murra; Gregory G Garwin; David G Cook; Warren C Ladiges; Satoshi Minoshima; Donna J Cross
Journal:  Brain Res       Date:  2016-12-05       Impact factor: 3.252

9.  Effects of genistein in the maternal diet on reproductive development and spatial learning in male rats.

Authors:  Evan R Ball; Mary Kay Caniglia; Jenna L Wilcox; Karla A Overton; Marra J Burr; Brady D Wolfe; Brian J Sanders; Amy B Wisniewski; Craige C Wrenn
Journal:  Horm Behav       Date:  2010-01-04       Impact factor: 3.587

10.  Traumatic Brain Injury in hTau Model Mice: Enhanced Acute Macrophage Response and Altered Long-Term Recovery.

Authors:  Olga N Kokiko-Cochran; Maha Saber; Shweta Puntambekar; Shane M Bemiller; Atsuko Katsumoto; Yu-Shang Lee; Kiran Bhaskar; Richard M Ransohoff; Bruce T Lamb
Journal:  J Neurotrauma       Date:  2017-11-01       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.